Jin Medical International Ltd. (ZJYL) AI Stock Summary

Snapshot

ZJYL is a tiny medical equipment maker whose business is shrinking. FY 2025 revenue fell 12% to $20.7M and net income dropped to $1.2M. The company holds a healthy cash balance of $29.6M against $18.9M in debt, but it recently executed a 1-for-20 reverse split. Management is moving forward with a plan to issue over 70 million new shares to buy a dormant company, which creates massive dilution for current owners.

What's Happening Right Now

• Wed 5th Aug '26 · Earnings: Revenue fell 9.7% year-over-year to $8.9M in the first half of fiscal 2026, swinging to a net loss.
• Mon 27th Jul '26 · Governance shift: Shareholders approved a $105M stock acquisition of a dormant company and increased Class B voting rights to 800 votes per share.
• Fri 5th Jun '26 · Auditor change: The company dismissed its auditor without the Audit Committee's recommendation and engaged a new firm.

Ownership

Institutions hold 0.1%, while insiders hold 0.0%.

Bottom Line

This micro-cap is displaying multiple warning signs. The recent reverse split is a classic signal of stock price distress. The bigger issue is the pending acquisition and governance overhaul, which involves issuing billions of authorized shares and boosting insider voting power to 800-to-1. This effectively wipes out the economic interest of existing shareholders to fund a deal for a company with no revenue.